We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-0.04%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$717M
AUM Growth
+$27.3M
Cap. Flow
+$32.6M
Cap. Flow %
4.54%
Top 10 Hldgs %
29.66%
Holding
2,758
New
211
Increased
1,430
Reduced
492
Closed
124

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$2.03M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$1.12M
3
MSFT icon
Microsoft
MSFT
+$1.03M
4
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$973K
5
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$970K

Top Sells

Rank Stock Value
1
HI
Hillenbrand
HI
+$571K
2
ALXN
Alexion Pharmaceuticals
ALXN
+$235K
3
XEC
CIMAREX ENERGY CO
XEC
+$159K
4
WORK
Slack Technologies, Inc.
WORK
+$142K
5
VZ icon
Verizon
VZ
+$134K

Sector Composition

Rank Sector Weight
1 Technology 12.64%
2 Consumer Staples 8%
3 Financials 7.08%
4 Consumer Discretionary 6.44%
5 Healthcare 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPC icon
2176
Pilgrim's Pride
PPC
$6.94B
$2K ﹤0.01%
66
-9
-12% -$226
PRAX icon
2177
Praxis Precision Medicines
PRAX
$8.8B
$2K ﹤0.01%
+8
New +$2.17K
PRDO icon
2178
Perdoceo Education
PRDO
$1.99B
$2K ﹤0.01%
148
-21
-12% -$236
PRGS icon
2179
Progress Software
PRGS
$1.59B
$2K ﹤0.01%
48
– –
PRLB icon
2180
Protolabs
PRLB
$1.85B
$2K ﹤0.01%
35
-1
-3% -$78
PSN icon
2181
Parsons
PSN
$6.36B
$2K ﹤0.01%
+53
New +$1.93K
QNCX icon
2182
Quince Therapeutics
QNCX
$17.5M
– –
0
– –
RARE icon
2183
Ultragenyx Pharmaceutical
RARE
$2.65B
$2K ﹤0.01%
25
+22
+733% +$1.99K
RCKT icon
2184
Rocket Pharmaceuticals
RCKT
$355M
$2K ﹤0.01%
61
-47
-44% -$1.71K
RDNT icon
2185
RadNet
RDNT
$4.84B
$2K ﹤0.01%
54
– –
RL icon
2186
Ralph Lauren
RL
$22.6B
$2K ﹤0.01%
19
+11
+138% +$1.27K
RPRX icon
2187
Royalty Pharma
RPRX
$26B
$2K ﹤0.01%
50
-217
-81% -$8.43K
SAH icon
2188
Sonic Automotive
SAH
$3.25B
$2K ﹤0.01%
47
+3
+7% +$152
SBH icon
2189
Sally Beauty Holdings
SBH
$1.43B
$2K ﹤0.01%
144
– –
SBSI icon
2190
Southside Bancshares
SBSI
$966M
$2K ﹤0.01%
57
– –
SCS
2191
DELISTED
Steelcase
SCS
$2K ﹤0.01%
+146
New +$2.01K
SM icon
2192
SM Energy
SM
$7.26B
$2K ﹤0.01%
71
-331
-82% -$6.69K
SPHR icon
2193
Sphere Entertainment
SPHR
$5.01B
$2K ﹤0.01%
32
+13
+68% +$974
SRDX
2194
DELISTED
Surmodics
SRDX
$2K ﹤0.01%
43
+17
+65% +$944
SRRK icon
2195
Scholar Rock
SRRK
$5.86B
$2K ﹤0.01%
56
-8
-13% -$280
SYNA icon
2196
Synaptics
SYNA
$4.55B
$2K ﹤0.01%
9
– –
TFIN icon
2197
Triumph Financial Inc
TFIN
$1.8B
$2K ﹤0.01%
23
– –
TRNO icon
2198
Terreno Realty
TRNO
$7.72B
$2K ﹤0.01%
24
-3
-11% -$200
TTMI icon
2199
TTM Technologies
TTMI
$12.8B
$2K ﹤0.01%
139
– –
UEIC icon
2200
Universal Electronics
UEIC
$57.6M
$2K ﹤0.01%
35
– –
86 87
88
89 90

Similar funds

BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $3.34B AUM 11.13% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM

Quadrant Capital Group's Q3 2021 Portfolio in Review

As of Q3 2021, Quadrant Capital Group held 2,758 positions worth $717M, up 4% from $689M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $32.6M of net new capital in Q3 2021, opening 211 new positions and adding to 1,430 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 3,278 shares worth $85K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Hillenbrand, an estimated $571K trimmed.

  • Quadrant Capital Group's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 3,278 shares worth $85K.
  • Quadrant Capital Group added most to iShares Russell 1000 ETF in Q3 2021, an estimated $2.03M increase.
  • Quadrant Capital Group's biggest Q3 2021 reduction was Hillenbrand, cutting an estimated $571K.
  • Quadrant Capital Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $235K.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $717M portfolio in Q3 2021.
  • Quadrant Capital Group opened 211 new positions and closed 124 in Q3 2021.
  • Quadrant Capital Group's portfolio value rose 4% quarter-over-quarter to $717M.

Based on Quadrant Capital Group's 13F filing for Q3 2021, filed 12 Nov 2021.